Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

NCRI 2013

3 - 6 Nov 2013
BT Convention Centre, Liverpool, United Kingdom
Variations in terminal sedation practices across the UK, Netherlands and Belgium
Dr Jane Seymour - Nottingham University, UK
Variations in terminal sedation practices across the UK, Netherlands and Belgium ( Dr Jane Seymour - Nottingham University, UK )
20 Nov 2013
Comparing toxicity profiles for 72 hour infusional and conventional bleomycin in...
Dr Jonathan Shamash - Barts Cancer Institute, London, UK
Comparing toxicity profiles for 72 hour infusional and conventional bleomycin in testicular cancer ( Dr Jonathan Shamash -  Barts Cancer Institute, London, UK )
15 Nov 2013
Polygenic susceptibility: What might it tell us?
Sir Bruce Ponder - University of Cambridge, UK
Polygenic susceptibility: What might it tell us? ( Sir Bruce Ponder - University of Cambridge, UK )
14 Nov 2013
Give early breast tumours fewer, larger doses of radiation, rather than more, sm...
Prof John Yarnold - The Royal Marsden, London, UK
Give early breast tumours fewer, larger doses of radiation, rather than more, smaller doses ( Prof John Yarnold - The Royal Marsden, London, UK )
14 Nov 2013
Diet, the microbiome, and colon cancer risk
Dr Stephen O' Keefe - University of Pittsburgh, USA
Diet, the microbiome, and colon cancer risk ( Dr Stephen O' Keefe - University of Pittsburgh, USA )
14 Nov 2013
UK fight for tobacco control
Prof Linda Bauld - University of Stirling, Stirling, UK
UK fight for tobacco control ( Prof Linda Bauld - University of Stirling, Stirling, UK )
14 Nov 2013
Engineering of polymeric nanoparticles for medical applications
Dr Omid Farokhzad - Harvard Medical School, Boston, USA
Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )
14 Nov 2013
DIfferences in prostate treatment between ROI and Northern Ireland, and measurin...
Dr Anna Gavin - North Ireland Cancer Registry, Queens University, Belfast, UK
DIfferences in prostate treatment between ROI and Northern Ireland, and measuring patient opinions ( Dr Anna Gavin - North Ireland Cancer Registry, Queens University, Belfast, UK )
13 Nov 2013
HPV prevalence in screened population and types associated with cervix disease
Dr Lesley Anderson - Queens University, Belfast, UK
HPV prevalence in screened population and types associated with cervix disease ( Dr Lesley Anderson - Queens University, Belfast, UK )
13 Nov 2013
Treatment decision making, screening and palliative care
Dr Jane Seymour - Nottingham University, UK
Treatment decision making, screening and palliative care ( Dr Jane Seymour - Nottingham University, UK )
13 Nov 2013
Biobanks, rare tumours and the importance of collecting primary material
Dr Andy Hall - Newcastle University, UK
Biobanks, rare tumours and the importance of collecting primary material ( Dr Andy Hall - Newcastle University, UK )
12 Nov 2013
Reduction cancer rates following the introduction of two-view mammography
Amanda Dibden - Queen Mary University London, UK
Reduction cancer rates following the introduction of two-view mammography ( Amanda Dibden - Queen Mary University London, UK )
12 Nov 2013
The DietCompLyf study: Breast cancer survival and phytoestrogen consumption
Dr Ruth Swann - University of Westminster, UK
The DietCompLyf study: Breast cancer survival and phytoestrogen consumption ( Dr Ruth Swann - University of Westminster, UK )
12 Nov 2013
The NCRN Pomi-T study: polyphenol rich whole food supplement slows PSA progressi...
Dr Robert Thomas - Cambridge University Hospitals, UK
The NCRN Pomi-T study: polyphenol rich whole food supplement slows PSA progression in prostate cancer ( Dr Robert Thomas - Cambridge University Hospitals, UK )
12 Nov 2013
Molecular imaging using PET-CT and personalised therapy with neuroendocrine tumo...
Dr Harshad Kulkarni - Zentralklinik, Bad Berka, Germany
Molecular imaging using PET-CT and personalised therapy with neuroendocrine tumours ( Dr Harshad Kulkarni - Zentralklinik, Bad Berka, Germany )
12 Nov 2013
The aTTom study: randomised comparison of continuing adjuvant in ER positive or ...
Dr Daniel Rea - University of Birmingham, UK
The aTTom study: randomised comparison of continuing adjuvant in ER positive or ER untested early breast cancer ( Dr Daniel Rea - University of Birmingham, UK )
12 Nov 2013
POSH study: Obesity and the outcome of young breast cancer patients
Dr Ellen Copson - University of Southampton, UK
POSH study: Obesity and the outcome of young breast cancer patients ( Dr Ellen Copson - University of Southampton, UK )
12 Nov 2013
The immune microenvironment as an anti-cancer therapeutic strategy
Dr Lisa Coussens - Oregon Science & Health University, USA
The immune microenvironment as an anti-cancer therapeutic strategy ( Dr Lisa Coussens - Oregon Science & Health University, USA )
12 Nov 2013
PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer
Dr Chris Gallagher - Barts and the London NHS Trust, UK
PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer ( Dr Chris Gallagher - Barts and the London NHS Trust, UK )
12 Nov 2013
Developing trials with surgeons: Hughes Abdominal Repair Trial (HART) Trial
Dr Julie Cornish - University of Cardiff, UK and Dr Andrew Torrace - University ...
Developing trials with surgeons: Hughes Abdominal Repair Trial (HART) Trial ( Dr Julie Cornish - University of Cardiff, UK and Dr Andrew Torrace - University of Birmingham, UK )
12 Nov 2013
Combined use of PET and MRI imaging
Dr Bernd Pichler - University of Tübingen, Germany
Combined use of PET and MRI imaging ( Dr Bernd Pichler - University of Tübingen, Germany )
12 Nov 2013
The molecular basis of cancer
Dr Gerard Evan - University of Cambrige, UK
The molecular basis of cancer ( Dr Gerard Evan - University of Cambrige, UK )
12 Nov 2013